Articles

Potential Alzheimer’s drug further backs protein hypothesis

The results of an experimental drug for Alzheimer’s disease provide the best evidence so far that the memory-robbing condition is caused by an errant protein in the brain. Drugmakers including Eli Lilly have been concentrating their Alzheimer’s research on that area.

Read More
Simon Breaking

Macerich rejects Simon Property’s $22.4B takeover bid

California-based mall owner Macerich Co. has rebuffed an unsolicited takeover bid from Simon Property Group Inc., saying it substantially undervalues the company and raises antitrust concerns. Analysts and investors expect Simon will make a higher bid.

Read More